Entrada Therapeutics Inc (TRDA)
Healthcare
Biotechnology
—
6.80 $
+0.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Entrada Therapeutics Inc (TRDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35 | -24 | -4.0 | -26 | 40 | -24 | -32 | -39 | -29 | -28 | -32 | -42 | -132 | |
| 0.7 | 0.8 | 0.7 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.2 | -2.8 | 0.8 | 0.3 | |
| 3.1 | 3.4 | 3.8 | 3.7 | 4.6 | 4.9 | 4.7 | 5.1 | 5.0 | 5.1 | 4.4 | 4.7 | 19 | |
| 1.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11 | -62 | 3.0 | -52 | -18 | -13 | -36 | -26 | 8.5 | 10 | 2.4 | -7.0 | 14 | |
| 1.5 | 1.4 | 1.0 | 0.8 | 1.0 | 0.6 | 0.6 | 1.1 | 0.3 | 0.2 | 0.2 | 0.0 | 0.7 | |
| -113 | -3.7 | 19 | 26 | -24 | -83 | 53 | 4.8 | 34 | 49 | 29 | 27 | 139 | |
| – | – | 0.4 | – | – | 0.3 | – | – | 0.3 | – | 0.1 | – | – | |
| 0.4 | 0.4 | 0.7 | 0.2 | 101 | 0.0 | 1.4 | 0.4 | 0.3 | 0.0 | 0.2 | 0.1 | 0.6 | |
| -148 | -28 | 16 | 0.8 | 117 | -107 | 23 | -33 | 4.6 | 21 | -2.9 | -15 | 7.9 | |
| -37 | -26 | -5.0 | -26 | 39 | -25 | -32 | -40 | -30 | -28 | -32 | -42 | -132 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.